Alnylam Pharmaceuticals Inc (ALNY)
NASDAQ · Healthcare
Alnylam Pharmaceuticals Inc Revenue 2008–2025
Alnylam Pharmaceuticals Inc annual/quarterly revenue history and growth rate from 2008 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Alnylam Pharmaceuticals Inc revenue for the quarter ending September 30, 2025 was 1.2 B, a 149.35% increase year-over-year.
- Alnylam Pharmaceuticals Inc revenue for the twelve months ending September 30, 2025 was 3.1 B, a 40.23% increase year-over-year.
- Alnylam Pharmaceuticals Inc annual revenue for 2025 was 3.7 B, a 65.19% increase from 2024.
- Alnylam Pharmaceuticals Inc annual revenue for 2024 was 2.2 B, a 22.97% increase from 2023.
- Alnylam Pharmaceuticals Inc annual revenue for 2023 was 1.8 B, a 76.23% increase from 2022.
- Alnylam Pharmaceuticals Inc annual revenue for 2022 was 1.0 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alnylam Pharmaceuticals Inc Earnings — FAQ
Alnylam Pharmaceuticals Inc (ALNY) earnings over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALNY's earnings history?
The chart and table above show Alnylam Pharmaceuticals Inc's earnings by year and by quarter, including the growth rate.